| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |